Mytrex Health Technologies, Inc. AI Stock Analysis
Mytrex Health Technologies, Inc. (4431) AI Stock Analysis
Mytrex Health Technologies, Inc.
(TPEx:4431)
No summary available
Mytrex Health Technologies, Inc. (4431) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 781.86M
- Dividend Yield
- ―
- Average Volume (3M)
- 60.14K
- Price to Earnings (P/E)
- -149.3
- Beta (1Y)
- 0.40
- Revenue Growth
- 7.43%
- EPS Growth
- 93.62%
- Country
- TW
- Employees
- 50
- Sector
- General
- Sector Strength
- 55
- Industry
- Industrial - Machinery
Mytrex Health Technologies, Inc. Business Overview & Revenue Model
Company Description
Established in 1990 and headquartered in Taoyuan, Taiwan, Mytrex Health Technologies, Inc. operates globally across Taiwan, Asia, Europe, and other international markets, specializing in the production and distribution of diverse non-woven fabrics. T...
Mytrex Health Technologies, Inc. Peers Comparison
Overall Rating
TW:418845Neutral
TW:412142Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4431 | Mytrex Health Technologies, Inc. | 21.40 | 4.45 | 26.25% | |
| TW:4121 | Rossmax International Ltd. | 12.25 | -3.15 | -20.45% | |
| TW:4188 | AmCad BioMed Corporation | 13.45 | -2.45 | -15.41% | |
| TW:4194 | Holy Stone Healthcare Co., Ltd. | 6.30 | -2.03 | -24.37% | |
| TW:6493 | TTBIO CORP. | 28.80 | -0.75 | -2.54% | |
| TW:6518 | Concord Medical Co Ltd | 29.85 | 4.98 | 20.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
